Table 1.
Demographic and baseline characteristics of patients with choroidal neovascularization secondary to angioid streaks.
| Mean ± std. deviation (relative frequency) | |
|---|---|
| No. of patients included | 29 |
|
| |
| No. of eyes included | 39 |
|
| |
| Female | 17 (58.6%) |
|
| |
| Age (years) | 53.0 ± 12.3 |
|
| |
| Both eyes affected | 10 (34.5%) |
|
| |
| PEX | 15 (51.7%) |
|
| |
| Age in PEX patients (years) | 49.0 ± 10.5 (P=0.023) |
|
| |
| PDT (eyes) | 5 (12.8%) |
|
| |
| CNV location | |
| Subfoveal | 13 (33.3%) |
| Juxtafoveal | 22 (56.4%) |
| Extrafoveal | 4 (10.3%) |
|
| |
| Baseline BCVA (ETDRS letters) | 59.3 ± 23.3 |
|
| |
| Baseline CMT (µm) | 343.3 ± 120.0 |
|
| |
| Follow-up (months) (minimum-maximum) | 69.4 ± 34.5 [36–135] |
BCVA: best-corrected visual acuity, CMT: central macular thickness, CNV: choroidal neovascularization, ETDRS: Early Treatment Diabetic Retinopathy Study, PDT: photodynamic therapy, PEX: pseudoxanthoma elasticum.